Brief: Iovance Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
22/03/2024 21:31
March 22 (Reuters) - Iovance Biotherapeutics Inc
IOVA.O :
* IOVANCE BIOTHERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER
NASDAQ
LISTING RULE 5635(C)(4)
Source text for Eikon: ID:nGNX49hrhc
Further company coverage: IOVA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies